No Detail Found!

Characteristics of health care workers with SARS-CoV-2 at a COVID-19 hospital in Türkiye: Homologous versus heterologous vaccination

Author(s)
Isıl Deniz Alıravcı Department of Infectious Diseases and Clinical Microbiology, Canakkale Onsekiz Mart University, Canakkale, Türkiye.
Yusuf Haydar Ertekin Department of Family Medicine, Canakkale Onsekiz Mart University, Canakkale, Türkiye.`
Gamze Can Department of Public Health, Canakkale Onsekiz Mart University, Canakkale, Türkiye.
Sevil Alkan Department of Infectious Diseases and Clinical Microbiology, Canakkale Onsekiz Mart University, Canakkale, Türkiye.
Abstract
Objective: Given the limited studies on types of vaccination and infection rates among health care workers (HCWs) in Türkiye, we analyzed the demographic, clinical, and vaccination characteristics as well as the attitudes of HCWs who have been infected with COVID-19. Methods: We retrospectively analyzed demographic and clinical data on breakthrough COVID-19 infections in HCWs from hospital surveillance data collected between April 5, 2020, and November 1, 2022. The comparison was based on four subgroups that consisted of unvaccinated, one-shot-vaccinated, homologous vaccinated, and heterologous vaccinated individuals. Participants who received various combinations of Sinovac/CoronaVac and/or BioNTech/Pfizer vaccines were compared for detection of COVID-19. Results: During a 33-month period of 744 HCWs who contracted COVID-19, women (65.3%) and nurses (28.9%) were the most afected, followed by doctors (25.8%). Of the infected HCWs, only 1.3% required hospitalization, 0.3% required ICU support, and 98.4% were outpatients. By vaccination status, 143 of the HCWs (19.2%) were unvaccinated, 292 (39.2%) were homologously vaccinated, 294 (39.5%) were heterologously vaccinated, 15 (2%) received a single shot, 206 (27.7%) received two shots, and 165 (22.2%) received three shots. All HCWs contracted COVID-19 at a mean of 134days (range:1-539) after vaccination. While the proportions of homologously and heterologously vaccinated HCWs were similar, the time elapsed from vaccination to contracting COVID-19 varied (mean 143.4±106.7 vs.126.4±82.43 days). Conclusions: Among both outpatients and inpatients with COVID-19, women HCWs outnumbered men HCWs. HCWs who received homologous vaccination contracted COVID-19 later than those who received heterologous vaccination.
Publication Details
Page(s) 1702-1708
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 8, Year: 2024

Request the full text from PASTIC

Keywords
COVID-19, SARS-CoV-2, vaccination, Covid-19, COVID-19 Vaccine, Health personnel, BNT162 Vaccine
References
.2023 .General coronavirus table. html (Access Date: September, 12 : .
Palacios R,Patiño EG,De Oliveira Piorelli R,Conde M,Batista AP,Zeng G .2020 .Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (Inactivated) vaccine manufactured by Sinovac - PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials, 10(1) : 853.
Dagan N,Barda N. .2021 .BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. , 10(15) : 1412-1423.
Haas EJ,Angulo FJ,McLaughlin JM,Anis E,Singer SR,Khan F .2021 .Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet, 6736(21) : 00947-8.
Yilmaz E,Ak R,Hökenek NM,Altıntaş MM,Batirel A,Demirhan R .2021 .Characteristics of the healthcare workers infected with the COVID-19 virus after receiving the first dose of coronavirus vaccine. South Clin Istanbul Euras, 10(3) : 241-244.
Sahu AK,Amrithanand VT,Mathew R,Aggarwal P,Nayer J,Bhoi S. COVID .2020 .-19 in health care workers - A systematic review and meta-analysis. Am J Emerg Med, 05(9) : 1727-1731.
Ujjan ID,Devrajani BR,Ghanghro AA,Shah SZA,COVID19-S4):COVID19-S12-S16 SZA .2020 .The clinical and demographical profile of Coronavirus illness: The tale of Tablighi Jamaat and Zaireen in Quarantine / Isolation center at Sukkur and Hyderabad. Pak J Med Sci, 10 : 2829-S4.
Abbas SW,Zareen SF,Saleem S,Tahir AB,Rasheed A,Sajid A .2020 .Comorbidities in fatal cases of sars-cov-2 in rawalpindi/islamabad pakistan. Pak Armed Forces Med, 70(1) : S232-S236.
Yang JY,Parkins MD,Canakis A .2020 .. Among Hospitalized Helth Care Workers in North America. JAMA Netw Open, 10(1) : .
Sharma P,Mishra S,Basu S. .2021 .Breakthrough Infection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Delhi: A Single-Institution Study. Cureus, 10(10) : .
Bandyopadhyay S,Baticulon RE,Kadhum M,Alser M,Ojuka DK,Badereddin Y .2020 .Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review. -003097, 10(12) : .
Lai X,Wang M,Qin C,Tan L,Ran L,Chen D .2020 .Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. , 10(5) : .
Abou-ElWafa HS,El-Gilany AH,Albadry AA .2021 .Self-reported COVID-19 among physicians: An Egyptian online study during the pandemic. F1000Res, 10 : 785.
Fusco FM,Pisaturo M,Iodice V,Bellopede R,Tambaro O,Parrella G .2020 .-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study. J Hosp Infect, 06(4) : 596-600.
Chandan S,Khan SR,Deliwala S,Mohan BP,Ramai D,Chandan OC .2022 .Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis. J Med Virol, 10(4) : 1428-1441.
Au WY .2022 .Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis. -069989, 10 : .
Amit S,Beni SA,Biber A,Grinberg A,Leshem E,Regev-Yochay G. Postvaccination COVID .2021 .. Israel. Emerg Infect Dis, 10(4) : 1220-1222.
Lin DY,Gu Y,Wheeler B,Young H,Holloway S,Sunny SK .2022 .Effectiveness of Covid-19 vaccines over a 9-month period in North Carolina. N Engl J Med, 10(10) : 933-941.
Whitaker HJ,Tsang RSM,Byford R,Andrews NJ,Sherlock J,Pillai PS .2021 .Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups. J Infect, 12(5) : 675-683.
Mayr FB,Talisa VB,Shaikh O,Yende S,Butt AA .2022 .Effectiveness of homologous or heterologous Covid-19 boosters in veterans. N Engl J Med, 10(14) : 1375-1377.
Alfaleh A,Alkattan A,Alzaher A,Radwan N,Mahmoud N,Alageel A .2022 .Protective duration of ChAdOx1 and BNT162b2 vaccines against SARS-CoV-2 infection. Clin Drug Investig, 10(10) : 799-806.
Fiolet T,Kherabi Y,MacDonald CJ,Ghosn J,Peiffer-Smadja N. Comparing COVID .2021 .-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect, 10(2) : 202-221.
Gerhards C,Thiaucourt M,Hetjens M,Haselmann V,Neumaier M,Kittel M. Heterologous M,Based M .2023 .-CoV-2 vaccination strategy appears superior to a homologous vector-based vaccination scheme in German healthcare workers regarding humoral SARS-CoV-2 response indicating a high boosting effect by mRNA vaccines. Vaccines (Basel), 10(3) : 701.
0

Citations

0

Downloads

51

Views